224 related articles for article (PubMed ID: 36059489)
1. CX3CL1-induced CD16
Tang J; Liao Z; Luo L; Deng S; Jiang Y; Wang F; Hu X; Yin H; Gong G; Feng J; Li X
Front Immunol; 2022; 13():929244. PubMed ID: 36059489
[TBL] [Abstract][Full Text] [Related]
2. CD14 expression is increased on monocytes in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis and correlates with the expression of ANCA autoantigens.
Tarzi RM; Liu J; Schneiter S; Hill NR; Page TH; Cook HT; Pusey CD; Woollard KJ
Clin Exp Immunol; 2015 Jul; 181(1):65-75. PubMed ID: 25766482
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients.
Hu X; Shen C; Meng T; Ooi JD; Eggenhuizen PJ; Zhou YO; Luo H; Chen JB; Lin W; Gong Y; Xiong Q; Xu J; Liu N; Xiao X; Tang R; Zhong Y
Front Immunol; 2022; 13():991469. PubMed ID: 36389826
[TBL] [Abstract][Full Text] [Related]
4. Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1-CX3CL1 interaction.
Roy-Chowdhury E; Brauns N; Helmke A; Nordlohne J; Bräsen JH; Schmitz J; Volkmann J; Fleig SV; Kusche-Vihrog K; Haller H; von Vietinghoff S
Cardiovasc Res; 2021 May; 117(6):1510-1522. PubMed ID: 32717023
[TBL] [Abstract][Full Text] [Related]
5. Altered circulating CCR6
Liao Z; Tang J; Luo L; Deng S; Luo L; Wang F; Yuan X; Hu X; Feng J; Li X
Arthritis Res Ther; 2021 Jul; 23(1):194. PubMed ID: 34289887
[TBL] [Abstract][Full Text] [Related]
6. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
[TBL] [Abstract][Full Text] [Related]
7. Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).
Manojlovic M; Juto A; Jonasdottir A; Colic J; Vojinovic J; Nordin A; Bruchfeld A; Gunnarsson I; Mobarrez F; Antovic A
J Mol Med (Berl); 2020 Sep; 98(9):1279-1286. PubMed ID: 32734361
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of protein A immunoadsorption and therapeutic plasma exchange in ANCA-associated vasculitis with severe renal involvement: a retrospective study.
Liu X; Xia M; Liu D; Liu H; Tang C; Chen G; Liu Y; Yuan F; Liu H
Ann Med; 2023 Dec; 55(1):2230875. PubMed ID: 37452682
[TBL] [Abstract][Full Text] [Related]
9. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
[TBL] [Abstract][Full Text] [Related]
10. [The clinical significance of circulating follicular helper T cells in patients with anti-neutrophil cytoplasmic myeloperoxidase antibody-associated vasculitis].
Wang S; Zheng MJ; Zhou XL; Liu YQ; Shuai ZW
Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):738-742. PubMed ID: 30293334
[No Abstract] [Full Text] [Related]
11. [The expression and clinical significance of neutrophil myeloperoxidase in patients with myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
Liu Y; Peng XC; Xu JN; Zheng MJ; Shuai ZW
Zhonghua Nei Ke Za Zhi; 2022 Sep; 61(9):1016-1022. PubMed ID: 36008294
[No Abstract] [Full Text] [Related]
12. CSF2-dependent monocyte education in the pathogenesis of ANCA-induced glomerulonephritis.
Rousselle A; Sonnemann J; Amann K; Mildner A; Lodka D; Kling L; Bieringer M; Schneider U; Leutz A; Enghard P; Kettritz R; Schreiber A
Ann Rheum Dis; 2022 Aug; 81(8):1162-1172. PubMed ID: 35418479
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma FXII is associated with disease activity in ANCA-associated vasculitis: A Retrospective Cross-Sectional Study in Western China.
Chen SS; Luo HJ; Li H; Zhang H; Li YY; Li Y; Wang W; Ding HL
Int Immunopharmacol; 2023 Dec; 125(Pt A):111067. PubMed ID: 37866310
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of astaxanthin on ANCA-associated vasculitis.
Sun RL; Shang JC; Han RH; Xing GQ
Int Immunopharmacol; 2024 May; 132():111928. PubMed ID: 38537540
[TBL] [Abstract][Full Text] [Related]
15. Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
Hamano Y; Ito F; Suzuki O; Koura M; Matsuoka S; Kobayashi T; Sugitani Y; Wali N; Koyanagi A; Hino O; Suzuki S; Sugamata R; Yoshizawa H; Yumura W; Maruyama N; Kameoka Y; Noda Y; Hasegawa Y; Arai T; Suzuki K
Autoimmunity; 2019; 52(5-6):208-219. PubMed ID: 31476889
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
Kim SM; Choi SY; Kim SY; Kim J
Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
[TBL] [Abstract][Full Text] [Related]
17. A novel 4-dimensional live-cell imaging system to study leukocyte-endothelial dynamics in ANCA-associated vasculitis.
Walls CA; Basu N; Hutcheon G; Erwig LP; Little MA; Kidder D
Autoimmunity; 2020 May; 53(3):148-155. PubMed ID: 31865776
[TBL] [Abstract][Full Text] [Related]
18. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
Mohammad AJ; Segelmark M
J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine-1-phosphate (S1P) enhances glomerular endothelial cells activation mediated by anti-myeloperoxidase antibody-positive IgG.
Sun XJ; Chen M; Zhao MH
J Cell Mol Med; 2018 Mar; 22(3):1769-1777. PubMed ID: 29168342
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal immune cell monitoring identified CD14
Matsumoto K; Suzuki K; Yoshimoto K; Seki N; Tsujimoto H; Chiba K; Takeuchi T
Arthritis Res Ther; 2020 Jun; 22(1):145. PubMed ID: 32546274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
